SCHEMBL19013129

SCHEMBL19013129

CCSC1CC(=O)N(CCNC(C)C)C1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 4/20 0.36
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.35
ALDH1A1 P00352 6/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HPGD P15428 1/20 0.34
KMT2A Q03164 3/20 0.33
MEN1 O00255 2/20 0.33
TDP1 Q9NUW8 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
MAPT P10636 1/20 0.31
CYP2C9 P11712 1/20 0.31
APEX1 P27695 1/20 0.31
CYP2C19 P33261 1/20 0.31
RECQL P46063 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
CYP19A1 P11511 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18885707 0.84 LMNA (0.40) FOLH1TSHRHTTALDH1A1LMNA
SCHEMBL22388963 0.84 FOLH1 (0.40) FOLH1TSHRHTTALDH1A1SMN1; SMN2
SCHEMBL10101925 0.80 CYP19A1 (0.45) FOLH1TSHRHTTALDH1A1SMN1; SMN2
SCHEMBL14327723 0.79 FOLH1 (0.39) FOLH1TSHRHTTALDH1A1SMN1; SMN2
SCHEMBL19636512 0.79 FOLH1 (0.44) FOLH1ALDH1A1SMN1; SMN2HPGDKMT2A
SCHEMBL22825220 0.78 CYP2C19 (0.36) TSHRALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL18885704 0.77 FOLH1 (0.34) FOLH1TSHRHTTALDH1A1SMN1; SMN2
SCHEMBL24368162 0.77 ALDH1A1 (0.50) FOLH1TSHRHTTALDH1A1KMT2A
SCHEMBL22931733 0.77 ALDH1A1 (0.44) FOLH1TSHRHTTALDH1A1SMN1; SMN2
SCHEMBL19981935 0.77 ALDH1A1 (0.32) ALDH1A1SMN1; SMN2KMT2AMEN1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11129910-B2 Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof HANGZHOU DAC BIOTECH CO., LTD. (CN) 2021-09-28 US disclosed
US-20200215206-A1 SPECIFIC CONJUGATION LINKERS, SPECIFIC IMMUNOCONJUGATES THEREOF, METHODS OF MAKING AND USES SUCH CONJUGATES THEREOF SUZHOU M-CONJ BIOTECH CO., LTD. (CN) 2020-07-09 US disclosed
US-10232051-B2 Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule HANGZHOU DAC BIOTECH CO., LTD. (CN) 2019-03-19 US disclosed
US-20170173168-A1 ACETYLENEDICARBOXYL LINKERS AND THEIR USES IN SPECIFIC CONJUGATION OF A CELL-BINDING MOLECULE SUZHOU M-CONJ BIOTECH CO., LTD. (CN) 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11129910-B2 Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof SLC25A1, GCDH, FH FOLH1 81/4885TSHR 3303/4885HTT 4672/4885
US-20170173168-A1 ACETYLENEDICARBOXYL LINKERS AND THEIR USES IN SPECIFIC CONJUGATION OF A CELL-BINDING MOLECULE AADAC, EPCAM, DCLRE1A FOLH1 53/4885TSHR 2628/4885HTT 4446/4885
US-20200215206-A1 SPECIFIC CONJUGATION LINKERS, SPECIFIC IMMUNOCONJUGATES THEREOF, METHODS OF MAKING AND USES SUCH CONJUGATES THEREOF SLC25A1, GCDH, FH FOLH1 81/4885TSHR 3303/4885HTT 4672/4885
US-10232051-B2 Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule AADAC, EPCAM, DCLRE1A FOLH1 53/4885TSHR 2628/4885HTT 4446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.